Company news

Novonesis A/S news

Latest news releases, newest first. Pick a year for every news release, call and deck from that year.

View company

Interim report Q1 2026

May 5, 2026

Resolutions from the Annual General Meeting 2026

March 23, 2026

Novonesis issues EUR 1.7 billion in bonds to refinance bridge facility

March 16, 2026

Novonesis issues EUR 1.7 billion senior unsecured notes

March 13, 2026

Invitation to the 2026 Annual General Meeting

February 26, 2026

Novonesis delivered strong organic sales growth of 7% in 2025

February 25, 2026

Novonesis delivered 8% organic sales growth in the first nine months of 2025

November 6, 2025

8% organic sales growth after first nine months. Full-year organic sales growth narrowed upwards.

November 6, 2025

Noma and Novonesis partner to scale deliciousness

October 23, 2025

Novo Holdings to make changes to its Board of Directors

October 21, 2025

Novonesis and Novo Nordisk will explore new solutions to improve metabolic health

September 8, 2025

Novonesis delivered 9% organic sales growth in H1 and full-year outlook range narrowed to 6-8%

August 21, 2025

Interim report H1 2025

August 21, 2025

2030 financial targets announced: Organic sales growth acceleration, margin expansion and ROIC improvement

August 20, 2025

Combining EVP roles of Human Health Biosolutions and Strategy & Integration

May 19, 2025

Novonesis delivered a strong Q1 with 11% organic growth and confirms full-year outlook

May 8, 2025

Interim report Q1 2025

May 8, 2025

Calls

The 5 newest of 25 calls. Every call is listed under its year.

Decks

The 5 newest of 110 decks. Every deck is listed under its year.